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Members of the SLC34 gene family of solute carriers encode
for three Naþ -dependent phosphate (Pi) cotransporter
proteins, two of which (NaPi-IIa/SLC34A1 and NaPi-IIc/
SLC34A3) control renal reabsorption of Pi in the proximal
tubule of mammals, whereas NaPi-IIb/SCLC34A2 mediates Pi
transport in organs other than the kidney. The Pi transport
mechanism has been extensively studied in heterologous
expression systems and structure–function studies have
begun to reveal the intricacies of the transport cycle at the
molecular level using techniques such as cysteine scanning
mutagenesis, and voltage clamp fluorometry. Moreover,
sequence differences between the three types of
cotransporters have been exploited to obtain information
about the molecular determinants of hormonal sensitivity
and electrogenicity. Renal handling of Pi is regulated by
hormonal and non-hormonal factors. Changes in urinary
excretion of Pi are almost invariably mirrored by changes in
the apical expression of NaPi-IIa and NaPi-IIc in proximal
tubules. Therefore, understanding the mechanisms that
control the apical expression of NaPi-IIa and NaPi-IIc as well
as their functional properties is critical to understanding how
an organism achieves Pi homeostasis.
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Homeostasis of Pi in higher organisms depends on the
coordinated transport of Pi across intestinal and renal
epithelia. Transport of Pi across the apical membrane is
mediated by the three members of the SLC34 family of solute
carriers.1 NaPi-IIa (SLC34A1) and NaPi-IIc (SLC34A3) are
specifically expressed in the brush border membrane (BBM)
of renal proximal tubules. NaPi-IIb (SLC34A2) has a broader
pattern of expression and it is highly abundant in the BBM of
small intestine. In both epithelia, the basolateral exit of Pi is
mediated by a transporter that remains unidentified. In the
proximal tubule it has been proposed that a Naþ -dependent
electroneutral anion exchanger is at least partially responsible
for Pi exit.
2
NaPi-IIa and NaPi-IIc mediate the reabsorption of Pi from
the primary urine by using the free energy provided by the
electrochemical gradient for Naþ . NaPi-IIa is electrogenic
and transports divalent Pi preferentially. It functions with a
strict Naþ :Pi stoichiometry of 3:1, which results in the net
inward movement of one positive charge per cotransport
cycle.3 NaPi-IIc, in contrast, is electroneutral and exhibits a
2:1 stoichiometry4,5 (Figure 1). In mice, NaPi-IIa is the
protein mainly responsible for Pi reabsorption in the adult
kidney, whereas NaPi-IIc appears to be more important in
weaning animals. Indeed, the phenotype of NaPi-IIa knock-
out mice first suggested that this cotransporter is responsible
for the bulk of renal Pi reabsorption with a very small
percentage potentially attributed to NaPi-IIc.6 However,
recent data indicate that in humans, NaPi-IIc may have a
previously unpredicted importance. The expression of NaPi-
IIa and NaPi-IIc is regulated to adapt the renal reabsorption
of Pi to the organism needs. Thus, the phosphaturic effect
associated with parathyroid hormone (PTH) is due to the
membrane retrieval of both cotransporters, whereas in
conditions of Pi deprivation their expression is increased.
4,7–9
The following sections summarize our present state of
knowledge of the regulatory and pathophysiological roles of
NaPi-IIa in renal Pi handling as well as its mechanism and
structure–function relations.
REGULATION OF NaPi-IIa EXPRESSION
Many hormonal and non-hormonal factors regulate renal
reabsorption of Pi (for review, see Murer et al.
10). The effect
of PTH and dietary Pi on NaPi-IIa has been the subject of
detailed investigation. These studies suggest that NaPi-IIa
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regulation depends on its shuttling to/from the BBM. This
contrasts with many other transporters, which activity is
modulated by modification of the transport protein itself
(e.g. phosphorylation, dimerization etc). This means that the
body’s requirements for a higher Pi reabsorption (i.e. after
low Pi-diet) are met by increasing the expression of NaPi-
IIa7,11,12 and NaPi-IIc4 at the BBM. For NaPi-IIa, acute
upregulation is independent of changes in transcription or
translation. Therefore, the increased expression of NaPi-IIa
must be owing to either the stabilization of the transporter at
the BBM or to an increased rate of insertion at the
membrane. Experimental data supports this dual mechanism.
Thus, dietary-induced upregulation depends on the presence
of scaffolding proteins,13 suggesting a stabilization action,
and on the microtubule network,11 suggesting an increased
rate of insertion. This latter mechanism requires the presence
of an intracellular pool of NaPi-IIa ready to be shuttled to the
membrane. Immunostainings of kidneys from rats fed
acutely a low Pi-diet have indeed revealed the presence of
NaPi-IIa in the Golgi apparatus, although this pool is not
detected with all immunostaining protocols.11
In contrast, reduced reabsorption of Pi (i.e. upon PTH
release or high Pi-diet) is achieved via downregulation of
NaPi-IIa8,11,14 and NaPi-IIc9 at the BBM. PTH-induced
downregulation of NaPi-IIa has been extensively studied and
the identifiable steps are summarized in Figure 2. Because
endocytosed cotransporters do not recycle to the BBM but
instead are degraded in lysosomes, recovery of NaPi-IIa basal
levels upon PTH removal depends on de novo synthesis. It is
therefore clear that apical retention/removal of NaPi-IIa must
be a regulated process, beyond the control of protein
turnover. We will now describe in detail the steps summar-
ized in Figure 2, integrating what is known about the
mechanisms that regulate NaPi-IIa expression with the role of
protein complexes.
Regulation of apical expression (step 1)
Apical expression of NaPi-IIa is dependent on its last three
residues (TRL, see Figure 4a). Truncation of these residues
leads to intracellular accumulation of the cotransporter,
suggesting an impaired sorting and/or stability of the
mutated protein.15 The TRL sequence represents a PDZ
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Figure 1 | Energetics of Pi reabsorption. In the BBM of proximal tubule epithelia, two Na
þ -coupled transporters, designated as NaPi-IIa
and NaPi-IIc, mediate apical uptake of Pi from the glomerular filtrate. Both are secondary active and drive Pi inward using the electro-
chemical free energy difference across the membrane for Naþ ions. NaPi-IIa is electrogenic and NaPi-IIc is electroneutral. With a typical
transmembrane Naþ concentration ratio of 10:1, the theoretical Pi concentrating capacity of NaPi-IIc is B100:1, whereas that for NaPi-IIa
isB10 000:1 because of its 3:1 Naþ :Pi stoichiometry and the additional driving force contributed by the transmembrane potential difference.
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(PSD-95, Discs-large and ZO-1) binding motif that interacts
with several PDZ proteins.16,17 PDZ domains, first described
in the early 1990s, comprise 80–100 residues distributed in six
b strands and two a helices. They bind to the carboxyl-
terminal tail (PDZ-binding motif) of the corresponding
ligand (for review, see Nourry et al.18). A conserved sequence
between the bA and bB strands of the PDZ domain (GLGF)
provides a hydrophobic pocket for ligand binding. Among
the PDZ proteins that interact with NaPi-IIa are the Na/H-
exchanger regulatory factors NHERF1 (EBP50) and NHERF2
(E3KARP) as well as PDZK1 (NHERF3), PDZK2 (IKEPP,
NHERF4), and Shank2E.16,17
NHERF1 and NHERF2 are two related proteins each
containing two PDZ domains and a C-terminal Merlin-Ezin-
Radixin-Moesin-binding domain.19–21 They are expressed in
the apical/subapical domain of murine proximal tubules,
respectively.16,22 NaPi-IIa binds to the first PDZ domain on
both proteins.16 Renal proximal cells (opossum kidney cells)
transfected with dominant-negative NHERF1 constructs23
and young NHERF1/ animals24 show a reduced amount of
NaPi-IIa at the BBM. In animals, this reduction associates
with urinary loss of Pi, a phenotype that reverts with age.
25
These findings suggest that NHERF1 contributes to stabilize
NaPi-IIa at the BBM. This stabilization depends on the
Merlin-Ezin-Radixin-Moesin-binding domain,23 which med-
iates binding to the actin-associated protein Ezrin. In
contrast to the effect on NaPi-IIa, deficiency in NHERF1
does not affect the expression of NHE3.24
PDZK1 and PDZK2 are related proteins, also expressed in
murine proximal tubules, each containing four PDZ
domains. In both cases, NaPi-IIa binds to the third PDZ
domain.16,26 Opossum kidney cells transfected with a
dominant-negative PDZK1 construct show reduced levels of
NaPi-IIa at the BBM.23 Although NaPi-IIa expression is
unaffected in normally fed PDZK1/ mice, its abundance
decreases when the animals are fed a high Pi-diet.
27 Thus, in
extreme dietary conditions PDZK1 may contribute to
stabilize NaPi-IIa at the BBM.
Shank2E is an epithelial-specific isoform of Shank2. The
three members of the Shank family share a similar domain
structure consisting of six N-terminal ankyrin repeats
followed by an SH3 domain, a PDZ domain, and a
proline-rich region.28 In rats, Shank2E is expressed at the
BBM of proximal tubules and, as for the other PDZ proteins,
association with NaPi-IIa requires the C-terminal TRL motif
of the cotransporter.17 Shank2 can bind dynamin,29 a
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Figure 2 | The downregulation of NaPi-Iia. Schematic representation of the sequence of steps involved in PTH-induced downregulation of
NaPi-IIa in an epithelial proximal tubule cell. Apical and basolateral membranes are separated by tight junctions (orange), to establish two
compartments for hormonal access.
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guanosine triphosphatase that mediates fission of endocytic
vesicles.30 Thus, Shank2E may connect NaPi-IIa with the
endocytic machinery.
PTH signaling (steps 2–4)
In the proximal tubule, PTH binds to apical and basolateral
receptors. Stimulation of either receptor leads to an increase
in urinary excretion of Pi as consequence of the reduction of
NaPi-IIa in the BBM.31 Apical application of PTH to isolated
proximal tubules activates preferentially the phospholipase
C/protein kinase C (PKC) pathway, whereas basolateral
application leads to activation of cyclic adenosine mono-
phosphate (cAMP)/protein kinase A (PKA) signaling.31 The
molecular explanation for this dual response may relay on the
presence (apical) or absence (basolateral) of NHERF. Thus, it
has been shown that NHERF associates with both the PTH
receptor and the phospholipase Cb1.32 The consequence of
this intermolecular association is the preferential activation
of phospholipase C upon binding of PTH to apical receptors.
In accordance with this mechanism, both 1–34 PTH (a
fragment that activates PKA and PKC) and 3–34 PTH (a
fragment that activates only PKC) fail to activate phospho-
lipase C in kidney slices from NHERF1/ mice.33 Despite
the heterogeneity of their initial steps, apical, and basolateral
PTH receptors use common downstream effectors. Mitogen-
activated protein kinase-kinase 1/2 inhibitors partially or
fully prevent the effect of both cascades, suggesting that the
PKC and PKA pathways coactivate extracellular signal-
regulated protein kinase 1/2.34 Interestingly, NHERF1 plays
a very different role in the regulation of NHE3, where acts as
a scaffold for PKA via association with the cAMP-kinase
associated protein Ezrin.35 Then, PKA phosphorylates (and
inhibits) NHE3 without initial changes in the expression of
NHE3 in the BBM.36 cAMP-induced inhibition of NHE3 can
be reproduced with cAMP analogs that activate exchange
protein directly activated by cAMP (EPAC1), whereas NaPi-
IIa is downregulated by PKA- but not by EPAC1-activating
analogs.37
PTH-induced endocytosis of NaPi-IIa (steps 5 and 6)
Binding of PTH leads to the axial movement of NaPi-IIa
along the microvilli and finally to its endocytosis from the
microvillar clefts.38,39 NaPi-IIa colocalizes with insulin upon
PTH administration, suggesting its internalization via
receptor-mediated endocytosis.40 This is further supported
by the finding that NaPi-IIa endocytosis is prevented in mice
with kidney-specific megalin deficiency and in receptor-
associate-protein-deficient mice.41 The immunostainings
shown in Figure 3 illustrate the route followed by NaPi-IIa
in response to PTH.40 Endocytosis takes place via clathrin-
coated pits and it is detected shortly upon PTH administra-
tion. Later on, NaPi-IIa is observed in clathrin-coated pits
and in endosomes (early endosome-associated protein 1
(EEA1) positive). Finally, the cotransporter is targeted to late
endosomes/lysosomes (lgp120 positive). Endocytosis associ-
ates with microtubule rearrangement, owing to the formation
of apical to basolateral oriented bundles.42 Prevention of
microtubular rearrangement or microtubular depolymeriza-
tion causes the delay of intracellular depletion of NaPi-IIa
(i.e. lysosomal degradation), although it does not affect its
downregulation (i.e. endocytosis).
Clathrin-mediated internalization of many proteins de-
pends on discrete intracellular sequences, among them
tyrosine (Y)- and dileucine (LL)-based motifs. These motifs
link the protein to be endocytosed to the adaptor protein
AP2 which in turn binds to clathrin (for review, see
Robinson43). AP2 is a heterotetramer consisting of a, b2,
m2, and s2 subunits. Y-based motifs bind to the m subunit
whereas LL-based motifs interact with the b subunit. NaPi-
IIa contains several putative Y- or LL-motifs (GY402FAM,
Y509RWF, LL101, LL374, and LI590) and two diacidic sequences
(EE81 and EE616) that can control lysosomal targeting.
Mutations of these motifs did not affect the PTH-induced
retrieval of NaPi-IIa.44 Instead, a dibasic sequence (KR)
within the last intracellular loop (Figure 4a) is required for
PTH sensitivity.45 These two positively charged residues are
replaced by uncharged residues (NI) in the PTH-insensitive
NaPi-IIb isoform. Swapping the specific residues inverts the
PTH sensitivity of the protein. The KR-containing loop, but
not a mutant with the KR sequence replaced by NI, interacts
with PEX19.46 In opossum kidney cells, NaPi-IIa endocytosis
is accelerated upon transfection of PEX19, suggesting a role
of this protein in the internalization of the cotransporter.46
NHERF1 and PDZK1 remain attached to the BBM upon
PTH administration; Deliot et al.,47 in preparation. This
suggests the disassembly of protein complexes before
internalization of NaPi-IIa. In opossum kidney cells, the
amount of NaPi-IIa that coimmunoprecipitates with
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Figure 3 | Immunohistochemical evidence for NaPi-IIa down-
regulation. Immunofluorescence of kidney slices incubated in the
absence or presence (5, 15, and 60 min) of PTH. Samples were
co-stained with antibodies against NaPi-IIa (green) and either
clathrin, EEA1, or lgp120 (red) antibodies.
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NHERF1 is reduced upon PTH treatment.47 Thus, PTH may
negatively regulate the association between NaPi-IIa and
NHERF1/PDZK1. PDZ-based interactions can be regulated
by phosphorylation of either the PDZ-binding motif or the
corresponding PDZ-domain. Studies using cell culture
models have demonstrated that NHERF1 is constitutively
phosphorylated, and the residues responsible for constitutive
and regulated phosphorylation have been identified.48–50
NHERF1 is also constitutively phosphorylated in mouse
kidney.47 Moreover, PTH, or pharmacological activation of
PKA and PKC induces phosphorylation of NHERF1, but not
of NaPi-IIa. PDZK1 is also constitutively phosphorylated in
kidney, and similar to NHERF1, PTH, or activation of
kinases, leads to an increase in its phosphorylation state
(N. De´liot, N Hernando, unpublished experiments). Thus,
we can hypothesize that phosphorylation of the PDZ-proteins
destabilizes their association with NaPi-IIa. According to a
recent report, PDZK1 is phosphorylated by PKA in Ser509
and this modification is required for upregulation of the
scavenger receptor class B type I.51
Like PTH, a high Pi-diet also induces downregulation of
NaPi-IIa.7,8,11,12 Although this process has not been studied
in the same detail as the PTH effect, endocytosed
cotransporters are also degraded in lysosomes.8,12 Thus,
PTH and Pi-diet may lead to similar cellular responses.
Expression of NHERF1 and PDZK1 remain unaffected upon
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Figure 4 | The NaPi-II protein. (a) Topological map of NaPi-IIa. This scheme is based on prediction algorithms and experimental data. The
NaPi-IIa monomer comprises twelve a-helical segments, four of which (yellow) have been confirmed by in vitro translation assays to span
the membrane.67 substituted cysteine accessibility method (see text) has revealed sites accessible from the external,69,70,72–74 (blue) and
internal71 (green) sides of the membrane, respectively. Two reentrant regions in each half of the protein, which comprise putative a-helical
segments 3–4 and 8–9 (boxed) and the preceding linkers, contain identical residues (pink). They are proposed to form the substrate
translocation pathway.75 A disulfide bridge in the large extracellular loop links the two halves of the protein. Regulatory sites include the
K-R motif45 (orange), important for PTH-induced internalization, located at the cytosolic end of a-helical domain 1115 and the triglyceride-rich
lipoproteins motif (violet) at the end of the C-terminal tail, involved in PDZ interactions.15 The large extracellular linker region contains two
N-glycosylation sites (black). Three sites were found critical for NaPi-IIa electrogenicity in the linker between a-helical segments 4–5 (red).5
(b) Evidence for NaPi-II dimers in the plasma membrane. Freeze fracture micrographs of the P face of the oocyte plasma membrane show a low
density of endogenous particles in a control oocyte (left) and an increased particle density in an oocyte expressing the flounder renal/intestinal
NaPi-IIb (center). Scale bar for both images: 200 nm. P Face¼protoplasmic face, ES¼ extracellular space; Cyt¼ cytosol. Statistical analysis of
particle diameter (right) suggests a homodimeric complex for NaPi-IIb proteins based on freeze-fracture analysis of other membrane proteins.86
Images and analysis courtesy of S. Eskandari, Biological Sciences Department, California State Polytechnic University, Pomona, CA, USA.
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changes in dietary Pi. However, Shank2E is endocytosed in
response to high Pi-diet.
17 As mentioned above, Shank2 can
bind dynamin II29 and therefore it could participate in the
linkage of NaPi-IIa with the endocytic machinery. In this
regard, Shank2E was shown to have a high rate of degrad-
ation even under low Pi-diet, suggesting its constitutive
association with the endocytic process.
NaPi-II COTRANSPORTERS AND HUMAN DISEASE
Several human disorders associate with renal Pi wasting. The
best characterized are X-linked hypophosphatemia, for which
two animals models (Hyp and Gy mice) are available,
autosomal dominant hypophosphatemic rickets, and heredi-
tary hypophosphatemic rickets with hypercalciuria (HHRH)
(for review, see Tenenhouse and Murer52).
Hyp and Gy mice show a reduced expression of NaPi-IIa
and NaPi-IIc.53,54 However, the primary defect does not
reside on the cotransporter genes. Instead, reduction of NaPi-
II is due to phosphate regulating gene with homology to
endopeptidases on the X chromosome (PHEX), a circulating
factor secreted by osteoblasts.55 PHEX has some homology
with metallopeptidases and it has been proposed that its role
is to degrade a phosphaturic factor which nature remains
controversial.
The gene responsible for autosomal dominant hypophos-
phatemic rickets has also been identified.56 It encodes
fibroblast growth factor-23 (FGF23), which is proteoliticaly
cleavaged at a furin site. In mice, infusion of FGF23 leads to
hyperphosphaturia owing to a reduction of NaPi-IIa in the
proximal BBM57,58 whereas FGF23 deficient mice show
hyperphosphatemia.59 Although it was proposed that
FGF23 may be a substrate of PHEX this remains to be
further confirmed.
HHRH is an autosomal recessive hypophosphatemic
disorder. Unlike other forms of hypophosphatemia, HHRH
associates with elevated levels of 1,25-dihydroxyvitamin D
which lead to increased intestinal reabsorption of calcium
and hypercalciuria.60 Because this phenotype is similar to the
one presented in NaPi-IIa-deficient mice6 it was postulated
that mutations in NaPi-IIa could be responsible for HHRH.
Several single nucleotide polymorphism on the NaPi-IIa gene
(NPT2 or SLC34A1) were detected in families affected by this
syndrome; however, no mutations predicted to affect the
protein were found.61 Heterozygous mutations on NaPi-IIa
have been reported in two patients with hypophosphatemia
associated with urolithiasis or bone demineralization62 and
initial reports suggested that the mutations affected the
apparent affinity for Pi and membrane targeting. However, an
extensive kinetic analysis of those mutants performed in our
laboratory63 as well as the phenotype of the heterozygous
NaPi-IIaþ / mice6 do not support the concept of these
heterozygous mutations being responsible for the human
disease. Recently, several groups reported homozygous
mutations in SLC34A3, the gene coding NaPi-IIc, in patients
with HHRH.64,65 Based on mice data, NaPi-IIc is predicted to
mediate not more than 30% of proximal reabsorption of Pi.
However, the above findings suggest a more critical role of
this transporter in the human kidney.
MOLECULAR MECHANISM OF Pi COTRANSPORT BY NaPi-IIa
The NaPi-IIa protein
Mammalian NaPi-IIa proteins are typically B640 amino
acids long with a glycosylated molecular weight of
B80–90 kDa.66 The secondary topology (Figure 4a) has been
determined from topology prediction algorithms and in vitro
translation assays,67 epitope tagging studies,68 and cysteine
scanning assays.69–74 The current model comprises 12
a-helical segments and a large extracellular loop that contains
two N-glycosylation sites with intracellular amino and
carboxyl tails. Four of the a-helical domains are proposed
to form two opposed reentrant segments (3, 4 and 8, 9) that
are speculated to associate and constitute the transport
pathway.75 Interestingly, these regions contain repeated
sequences that are conserved in all eukaryotic NaPi-II
isoforms,71,76 as well as in the bacterial homolog from Vibrio
cholerae.77 This strongly suggests a common structure–func-
tion motif among Naþ -driven Pi cotransporters that has
been preserved throughout the course of evolution. One
disulfide bridge, in the large extracellular loop, most likely
serves to define the tertiary structure and links the two halves
of the protein. This bridge has been shown to be essential for
functional expression76 and the two halves have not been
successfully expressed individually.74,78 A second disulfide
bridge linking cysteine residues within the hydrophobic core
of the protein has also been proposed, although the cysteine
pair involved is less certain.76,79
Homomultimeric assembly is a feature of channel
proteins: the oligomerization can be essential for function
as in the case of tetrameric Kþ channels80 or a structural
requirement as in the case of the dimeric Cl channels.81
Multimeric assemblies of carrier proteins have also been
proposed (e.g.82Kilic and Rudnick; 83Eskandari et al.) and
recently the crystallization of a bacterial glutamate transpor-
ter homolog revealed a trimeric assembly.84 These findings
prompt two questions: what is the functional unit of NaPi-II
proteins and do they oligomerize in vivo? To answer the first
question, we performed coexpression experiments with the
wild–type (WT) NaPi-IIa and a selectively inhibitable mutant
NaPi-IIa, as well as experiments using an engineered
concatamer comprising the WT and the same mutant. Our
findings established conclusively that the NaPi-IIa protein is a
functional monomer.85 With regard to the second question,
compelling evidence has emerged in favor of the dimerization
of NaPi-IIa in situ: the freeze fracture technique86 applied to
Xenopus oocyte membranes containing the flounder renal/
intestinal NaPi-IIb revealed membranous particles, with a
mean diameter of 7.5 nm that would be consistent with a
dimeric assembly of NaPi-IIb proteins (Figure 4b, S
Eskandari, personal communication). This conclusion is also
supported by evidence from two other approaches: (1) appli-
cation of the split ubiquitin method to detect protein–protein
interactions87 confirmed that NaPi-IIa can self-associate
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in vitro and (2) by means of dual tagging, dimerization was
documented for NaPi-IIa expressed in Xenopus oocytes.87
Transport mechanism
The basic kinetic characteristics of renal proximal tubular
Naþ -Pi cotransport were determined using BBM vesicles
before the identification of the proteins responsible (for
review, see Murer et al.66). With the exception of the issues
of electrogenicity and the identification of the preferred
species of Pi cotransported, both of which could not be
clearly resolved from these earlier studies alone, the kinetic
fingerprint has remained essentially the same after expression
cloning and functional characterization of the NaPi-II
proteins in heterologous expression systems. Its features
are: (1) a strict dependency on external Naþ as the driving
substrate, with an apparent affinity of Naþ of B50 mM, (2)
a specificity for Pi as the driven substrate with an
apparent affinity of p0.1 mM, and (3) a strong depen-
dency on external pH, whereby extracellular acidification
diminishes Pi uptake.
By means of expression cloning, the identification of the
NaPi-IIa protein as the principal mediator of Naþ -coupled
Pi uptake in the mammalian kidney and the expression in
Xenopus oocytes of different NaPi-IIa isoforms has allowed
more detailed kinetic studies to be performed. The first of
these documented the electrogenicity of NaPi-IIa.88 When the
membrane potential of a Xenopus oocyte overexpressing
NaPi-IIa is measured in the presence of Naþ , application of
Pi causes membrane depolarization, consistent with an
inwardly directed net positive charge movement; restoration
of the cell resting potential occurs after removal of Pi
(Figure 5a). Moreover, when the membrane potential is fixed
to a value in the physiological range (i.e. the oocyte
membrane is voltage clamped), Pi induces inward currents
that are membrane potential dependent (Figure 5b). Under
the assumption that the electrogenic activity is a direct
reflection of the transport activity, these basic findings led to
the proposal that the NaPi-IIa protein operates with a Naþ :Pi
stoichiometry of 3:1 at physiological pH (7.4), where divalent
Pi predominates. However, there was still uncertainty about
the selectivity of the transporter for divalent versus mono-
valent Pi and the influence of external pH, which itself
determines the availability of the Pi species (e.g.
88,89Busch
et al.;90 Hartmann et al.). This issue was resolved unambi-
guously by simultaneous measurement of net charge transfer
and substrate flux on the same oocytes.3,91 Moreover, these
studies confirmed that NaPi-IIa preferentially transports
divalent Pi, independently of the external pH.
Two other properties of electrogenic NaPi-II proteins are
presteady-state charge movements and uncoupled leak
currents. When challenged by a step change in membrane
potential, NaPi-IIa expressing oocytes exhibit nonlinear
charge movements, termed presteady-state relaxations, which
have been reported for nearly all electrogenic cotransporter
systems so far studied (for review, see Forster et al.92). The
detection of these charge movements provided the first, albeit
indirect, evidence that voltage-driven molecular conforma-
tional changes occur during the transport process, analogous
to the gating currents that precede the opening of voltage
gated channels (e.g. Bezanilla93). For NaPi-IIa, relaxations are
observed in the presence and absence of external Naþ
(Figure 5c): in the latter case, the relaxations are hypothesized
to reflect a voltage-driven reorientation of the empty carrier.
Such a reorientation would be consistent with an alternating
access type model for the uphill movement of solute, in
which the protein exposes substrate binding sites either to the
external or internal media, but not both at the same time. In
the former case, additional charge movement reflects the
movement of Naþ ions to and from their binding sites,
located within the transmembrane electric field. The
existence of such voltage-dependent processes implies that
in addition to substrate activity, membrane potential is also a
determinant of the transport rate (Figure 5a–c). Note that the
electroneutral NaPi-IIc4 does not exhibit presteady-state
relaxations.5
Recent findings have prompted a reconsideration of what
distinguishes passive channels from active carriers (e.g.
DeFelice94): channels can display carrier-like behavior95 and
carriers can display channel-like behavior (e.g. Sonders and
Amara96). Moreover, the changes at the molecular level that
affect the switch between modes can be minor. For
electrogenic members of the NaPi-II family, the Pi transport
inhibitor foscarnet (phosphonoformic acid) was shown to
inhibit a Naþ -dependent leak current97 associated with
expression of NaPi-IIa protein in oocytes. Ion-replacement
experiments also indicate the involvement of other ions
including chloride and suggest a more complex leak pathway
than hitherto proposed (I.C. Forster and A. Bacconi,
unpublished experiments). Based on studies of mutant
NaPi-IIa proteins, the leak and cotransport modes appear
to be mutually exclusive,75 although it has proven experi-
mentally difficult to establish this conclusively for the WT
protein. Furthermore, recent studies on the temperature
dependency of NaPi-II indicate that the activation energy for
the leak mode is more consistent with a carrier type
mechanism than that of a channel (A. Bacconi and I. Forster,
unpublished experiments). The NaPi-IIa leak current ac-
counts for B10% of the maximum Pi-induced current
(although some engineered NaPi-IIa mutants exhibit sig-
nificantly larger leaks (e.g.71,75Kohler et al.; 72Virkki et al.;
and 73,74Ehnes et al.). The physiological significance of these
leak currents is yet to be determined and in the proximal
tubule with NaPi-IIa operating near Vmax conditions, its leak
current is probably inconsequential. It remains to be clarified
whether the NaPi-IIa leak current results from translocation
of ions by the NaPi-IIa monomer or through a gated pore
formed by the putative dimer.
The combined findings of kinetic studies on WT NaPi-IIa
proteins have resulted in a kinetic scheme for the transport
cycle (Figure 5d). This comprises a sequence of partial
reactions in which ordered substrate binding occurs91,97,98
and is consistent with an alternating access model in which
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states 1–4 and 5–8 represent ‘outward’ and ‘inward’ facing
conformations, respectively. Recent voltage clamp fluoro-
metry (VCF) studies99 provide compelling evidence that two
Naþ ions precede the Pi interaction, in contrast to our earlier
scheme based on electrophysiological measurements alone,
which postulated a single Naþ ion interaction.97 The first
Naþ interaction (1–2a) is proposed to be electroneutral,
which is followed by the movement of a second Naþ ion into
the transmembrane field that gives rise to the resolvable
charge movements. In the absence of Pi, the system can cycle
via the leak pathway: phosphonoformic acid is thought to
compete directly with the Pi binding transition and protons
20
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Figure 5 | NaPi-IIa kinetics. (a–c) The electrogenicity of NaPi-IIa studied using Xenopus oocytes. (a) An oocyte expressing NaPi-IIa is impaled
with a microelectrode to measure the transmembrane potential (Vm). Application of 1 mM Pi in the presence of 100 mM Na
þ induces membrane
depolarization consistent with net translocation of charge. No change in Vm occurs in the absence of Na
þ . (b) Impalement of the same oocyte
with two intracellular electrodes together with an additional amplifier allows clamping the membrane potential according to an external
command (Vc) and measurement of the transmembrane current (Im). Application of Pi in the presence of Na
þ induces an inwardly
directed current that is also voltage dependent. (c) With the same measurement system as in (b), step changes in Vm induce transient current
relaxations (presteady-state currents) that are also observed in the absence of substrate. In choline they reflect the movement of mobile
charges intrinsic to the NaPi-IIa protein; with added 100 mM Naþ , additional charge movement reflects movement of Naþ ions within the
transmembrane field. (d) Kinetic scheme for the NaPi-IIa transport cycle. This comprises an ordered sequence of partial reactions between
different conformational states, indicated by the numbers. At least two partial reactions (red) involve charge movement within the
transmembrane electric field: the empty carrier (1–8) and Naþ binding (2a–2b). They confer voltage dependency to the transport cycle. The
partial reactions affected by protons, Liþ , and phosphonoformic acid are indicated. Transitions between the postulated inward-facing
conformations (5–8) have not been characterized. The leak mode (light blue) involves the translocation of Naþ ions before Pi binding.
In the presence of Pi, the complete cotransport cycle (dark blue) is adopted. The translocation of the fully loaded protein (three
Naþ ions and one divalent Pi) takes place via an electroneutral transition (4–5): we assume that the carrier itself provides one net negative
charge, which accounts for the presteady charge movements in choline (c). Finally, on the cytosolic side, we assume that the substrates are
released sequentially. The substrate debinding leaves the empty carrier in an unfavorable conformation (for a negative intracellular potential)
so that it returns to an outward facing conformation (state 1) for the next cycle. (Figure 5 continued on following page.)
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interact at multiple sites as they affect both the empty carrier
and Naþ binding partial reactions.91,98
How fast does NaPi-IIa transport? Using steady-state and
presteady-state electrophysiological data, the turnover rate of
NaPi-II proteins has been recently compared for several
isoforms.100 The data suggest rates in the range 4–10 s1 at
201C. As the NaPi-IIa kinetics are strongly temperature
dependent (I.C. Forster, A. Bacconi unpublished data), we
would expect values at least threefold higher under normal
physiological conditions.
Probing NaPi-II proteins for structure–function relationships
Structure–function studies are used to identify molecular
elements responsible for the observed transport character-
istics, for example, substrate binding/interaction sites,
voltage-sensing elements, and transport pathways etc. These
studies can also yield topological and conformation informa-
tion. Typically, these approaches rely on site-directed
mutagenesis, covalent linking of reporter probes at specific
sites and engineering chimeras derived from isoforms with
different kinetic characteristics.
We have applied the substituted cysteine accessibility
method101 to probe the NaPi-IIa protein for functionally
important sites.69–74 substituted cysteine accessibility method
involves replacing amino acids individually by cysteines and
then probing the mutant with cysteine-reactive methanethio-
sulfonate (MTS) reagents. Surface labeling of accessible
cysteines can be confirmed by immunohistochemistry using
MTS-biotin, and if the transport function is also modified,
the accessibility of the site using different MTS reagents (size
and charge) can be quantified (for review, see Forster et al.92).
We first used substituted cysteine accessibility method to
investigate the loops that link predicted membrane spanning
regions69–71,73,74 and thus confirmed their membrane orien-
tation. Scanning of the predicted transmembrane spanning
domain 5 (Figure 4a) indicated that this region is most likely
inaccessible from the external medium and that it contains
residues possibly involved in coordinating Naþ ions.72 An
a-helical region was proposed from the periodical accessibility
of sites in part of the second reentrant motif (Figure 4a, 9),
consistent with the predictions of a hidden Markov analysis
of the NaPi-IIa primary sequence.67 Cysteine substitution
in the linker stretches between domains 1, 2 and 11, 12
markedly affected the voltage dependency of the cotransport
mode and this behavior suggested that the preferred
orientation of the empty carrier (inward or outward facing)
may be influenced by the flexibility of these linker
stretches.73,74
The cloning of an electroneutral Naþ -coupled Pi
cotransporter (NaPi-IIc),4 which shows a high degree of
sequence similarity to the electrogenic NaPi-IIa, particularly
in the predicted membrane spanning regions, offered a
unique opportunity to gain new insight into the NaPi-II
transport mechanism. We first established that NaPi-IIc
cotransports with a 2:1 Naþ :Pi, stoichiometry, consistent
with its electroneutrality. Then, by means of a combination
of engineering chimeras between each isoform, detailed
sequence comparison, and site-directed mutagenesis, we
identified conserved sites in each isoform that are critical
for conferring electrogenicity (Figure 4a).5,72 Substitution of
three amino acids found at the equivalent sites in NaPi-IIa
(see Figure 4a) conferred electrogenic behavior, including 3:1
Naþ :Pi stoichiometry, to the electroneutral NaPi-IIc and,
moreover, robust presteady-state relaxations were documen-
ted. Significantly, this finding demonstrated that relatively
minor changes to the amino-acid sequence could establish a
novel Naþ binding site and a concomitant change of the
cotransport stoichiomety. Such molecular engineering does
not come without a price: the electrogenic NaPi-IIc mutant
exhibits a significantly reduced affinity for Pi compared with
the WT NaPi-IIc (and NaPi-IIa) and a weaker dependency on
membrane potential. These modified characteristics clearly
indicate that other sites contribute to the kinetic fingerprint
of NaPi-IIa.
The complexity and duplicity of structure–function
relationships is also exemplified by our finding that similar
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alterations in a macroscopic kinetic property can be effected
by changes at different sites in the protein: for example,
substituting a cysteine for a serine at the top of a- helical
region 9 (Figure 4a), leaves the electrogenic behavior
essentially unchanged.69 Modification of this site using
MTS reagents fully inhibits cotransport activity, but retains
the leak. Yet, exactly the same phenotype can be observed by
simply replacing a native asparagine in a- helical region 4
(Figure 4a) with charged or bulkier amino acids.71 This may
suggest an interaction of these two regions with the transport
pathway, but does not exclude other explanations.
Recently the application of VCF (e.g. Cha et al.102), has
revealed new structure–function relations of the NaPi-II
protein. VCF combines electrophysiology and fluorescence
microscopy, whereby specific sites of the protein are labeled
with a fluorophore to report changes in the fluorophore’s
local environment in real-time under voltage clamp. One
advantage of VCF is its potential to reveal local conforma-
tional changes, in contrast to presteady-state charge move-
ments that may reflect global changes because the mobile
charges could be distributed throughout the protein. In the
first application of VCF to NaPi-II proteins, we used a
mutant NaPi-II that shows no cotransport activity after MTS
labeling,69 yet, electrophysiological evidence indicates that
substrates can still interact with the protein. This property
implies that the number of possible conformational states
(Figure 5d) is reduced, thus making data interpretation
easier. The dependency of the fluorescence changes with
external Naþ indicated that two Naþ ions can interact with
the protein before Pi binding (Figure 5d) and that Li
þ ions,
which do not support cotransport, also interact with the first
Naþ binding reaction.99 In another VCF study, we have
recorded fluorescence changes independently from four
labeled sites located in externally accessible linker regions.
Importantly, the labeling of these sites did not significantly
alter cotransport function.103 The dependency of fluorescence
changes on substrate and membrane potential indicated
that complementary conformational changes take place
during the transport cycle in the two halves of the protein,
when measured from their respective local environments.
These VCF studies offer a first glimpse of the molecular
rearrangements taking place at specific sites during substrate
interaction and translocation in real time.
OUTLOOK
At the physiological level, we still do not fully understand
many aspects of renal phosphate handling. Recent evidence
that NaPi-IIc cotransporters may (in humans) play a more
important role than expected9 will necessitate more detailed
studies at the whole animal and at the cellular levels.
Adaptation of renal Pi handling in response to changing
dietary Pi is a well-documented phenomenon, yet the
systemic and local signaling pathways remain to be
elucidated. From the systemic viewpoint, one might
hypothesize that a Pi sensor is involved, which would require
identification. Recently, tantalizing evidence has emerged
from experiments that suggest that the Pi concentration in
the third ventricle may influence the abundance of NaPi-IIa
cotransporters.104 Whether or not this is achieved via a
neural pathway remains to be determined. On the other
hand, alterations of blood Pi may provoke yet unknown
hormonal responses that lead to changes in gene transcrip-
tion or influence translation in the proximal tubular
epithelia. Hormonal influences on the abundance of NaPi-
IIa protein in the proximal tubular apical membrane are well
described, yet in most cases we still do not understand the
signaling mechanism that earmarks the protein for inter-
nalization, the phosphorylation reactions involved, whether or
not the abundance of NaPi-II protein is indirectly affected by
interacting proteins and the rate of endocytosis. Finally, the
mechanism of apical sorting and targeting of type II Naþ /Pi
cotransporters to the membrane remains to be elucidated.
At the molecular level, structural information as obtained
from two- or three-dimensional crystallization of the NaPi-II
protein will be essential to fully understand its transport
mechanism, identify substrate coordination sites, the trans-
membrane transport pathway and resolve mechanistic issues
concerning the nature of the carrier versus channel-like
behavior this protein. This will complement our ongoing
efforts to determine structure–function relationships using
indirect biochemical and biophysical methods as described
above. Furthermore, basic kinetic studies will also be required
to elucidate the internal steps of the transport pathway by
gaining access to the intracellular milieu. We should
emphasize that this review has concentrated on what is
known about the movement of Pi across the apical
membrane of proximal tubule cells. Yet, it is obvious that
an essential link in the overall movement of Pi from
glomerular filtrate to blood still remains undefined, namely
the mechanism and identification of the proteins responsible
for basolateral exit of Pi.
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